Advance-HTA Capacity Building Workshop

Mexico City, 6-7 November 2014


Rational

In recent years HTA has become part of the agenda of Latin American countries. Many countries have implemented legislation and institutional changes related to HTA and its application to support the decision-making process. Yet, there is a considerable heterogeneity both across but also within countries and many issues remain to be resolved.

Latin American countries are increasingly embracing HTA activities and are looking towards Europe for adaptation, knowledge and information to update their capacity and skills. The Advance-HTA Capacity Building Workshop is therefore an opportunity to build HTA capacity, outline the options available for decision-makers and debate the actions required for this purpose, tailor-made for the needs of the countries in this region.


Objectives

  • Introduce the principles, models and structure of HTA, including specific considerations for pharmaceuticals, medical devices and orphan medicinal products.
  • Showcase best practices and lessons learned from countries that already use HTA.
  • Provide recommendations for the strengthening and the implementation of HTA as a tool for decision-making and efficient resource allocation at national level (as well as supra-national and international levels).
  • Discuss future developments in HTA and their policy implications
  • Foster international collaboration and create a network for exchange of expertise.


The workshop took place in Mexico City, on 6-7 November 2014. It was organized by Advance-HTA with additional support from CENETEC-SALUD, the National Center for Excellence in Health Technology of Mexico.

The workshop was attended by 59 participants, mainly policy makers working in public institutions such as Ministries of Health, Health Insurance Funds, Social Security Institutes and HTA Agencies. In total, 14 countries were represented: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, El Salvador, Mexico, Paraguay, Peru, Trinidad and Tobago, and Uruguay.


Agenda and Resources

The 2-day workshop included 6 sessions:

  • Introduction to HTA
  • HTA and Decision Making Experiences in the Americas
  • Critical Issues in Appraisal of Medical Technologies
  • What Could Latin American Countries Learn from Other Jurisdictions?
  • HTA in Context
  • Current Patterns and Future Directions in HTA Implementation in Latin America

Click here to access the full program.


All presentations delivered during the workshop are provided below:

HTA: Models, Costs and Benefits

Processes and Evidence Requirements

HTA in Colombia: first two years of the HTA Agency

Incorporation decisions in the Public Health System in Brazil: the experience of CONITEC

Experience of CENETEC in Mexico

HTA capacity in Costa Rica

Value for money

Value assessment methods and application of Multiple Criteria Decision Analysis for HTA

Multiple Criteria Decision Analysis: experience in Latin America

Methods of preference elicitation: EQ5D and measures of utility in Latin America

The NICE experience

HTA in Central and Eastern European Countries

HTA in Spain

Rapid assessments: what is their role in supporting decision making?

Transferability of HTA results

HTA and Beyond: Risk sharing agreements and other innovative mechanisms


Feedback

Based on feedback received from participants, the workshop was a success in terms of quality of speakers, program’s structure and content, and general workshop’s administration. In fact, more than 80% stated the workshop met their expectations and 95% would recommend the workshop to colleagues.

“I was delighted with the program prepared for the workshop and with all the lecturers; their capacity for sharing their knowledge allowed us to learn diverse topics.”

“Congratulations to the organizers, speakers and hosts for an excellent workshop!”

“Thank You all for this excellent HTA Workshop. I hope to participate soon again in another similar one.”


Future Activities

A second HTA Capacity Building Workshop for Latin America is in plan and will take place towards the end of 2015 (TBD). It will be an opportunity to showcase the results of Advance-HTA research activities.

Acronym ADVANCE_HTA
Full title Advancing and strengthening the methodological tools and policies relating to the application and implementation of Health Technology Assessment (HTA)
Project number 305983
CoordinationLSE Health
Consortium 13 partners

The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement No. 305983.